Polycythaemia vera (PV) is a type of rare blood cancer called a myeloproliferative neoplasm (MPN). These are conditions that cause an increase in the number of blood cells. Research helps us find out ...

Polycythaemia vera (PV) is a rare blood cancer that affects the bone marrow. It causes your body to make too many red blood cells. To find out if you have polycythemia vera your doctor will do several ...

See the committee papers for full details of the evidence. 3.1 Polycythaemia vera is a bone marrow condition that leads to an increase in the number of cells in the blood. It mostly affects the number ...

Ruxolitinib (trade name: Jakavi) has been approved since March 2015 for the treatment of adults with polycythaemia vera, a rare disease of the bone marrow. It can be used when the drug hydroxyurea ...

Ruxolitinib (trade name: Jakavi) has been approved since March 2015 for the treatment of adults with polycythaemia vera, a rare disease of the bone marrow. It can be used when the drug hydroxyurea ...

Norman Swan: Polycythaemia vera is a rare disorder where the bone marrow produces too many red blood cells. These excess cells can be deadly, thickening the blood and causing organ damage and strokes.

This page lists all known medications that could potentially lead to 'Polycythaemia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Suggested remit - To appraise the clinical and cost effectiveness of ropeginterferon alfa-2b within its marketing authorisation for treating polycythaemia vera without symptomatic splenomegaly 24 July ...